EUVIMEDEUVIMED entdecken
Vergleichsstudie

Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention

Mauro Gitto, Samantha Sartori, Birgit Vogel, Pier Pasquale Leone, Kenneth Smith, Benjamin Bay, Prakash Krishnan, Joseph Sweeny, Angelo Oliva, Pedro Moreno, Sean Gilhooley, Francesca Maria Di Muro und 5 weitere

Canadian Journal of Cardiology · 2025

DOI: 10.1016/j.cjca.2025.02.035 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Canadian Journal of Cardiology, 2025. Verfasst von Mauro Gitto und 16 weiteren Autor:innen. Beteiligte Einrichtung: Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Sciences, Humanitas Uni…. Hauptthemen laut MEDLINE: Purinergic P2Y Receptor Antagonists, Percutaneous Coronary Intervention, Neoplasms, Ticlopidine. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 41 Literaturangaben. Gefördert von: German Heart Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Purinergic P2Y Receptor AntagonistsPercutaneous Coronary InterventionNeoplasmsTiclopidineHumansClopidogrelMaleFemaleAgedMiddle AgedRetrospective StudiesPrasugrel HydrochloridePropensity ScorePlatelet Aggregation InhibitorsTicagrelorHemorrhage

Substanzen

ClopidogrelPurinergic P2Y Receptor AntagonistsTiclopidinePrasugrel HydrochloridePlatelet Aggregation InhibitorsTicagrelor

Autor:innen und Institutionen

  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Italy.
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA.
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA; Department of Cardiology, University Heart & Vascular Centre Hamburg, University Medical Centre, Hamburg-Eppendorf, Ge…
  • Mount Sinai Fuster Heart Hospital, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: roxana.mehran@mountsinai.org.

Förderung

  • German Heart Foundation

Zitieren

APA

Gitto, M., Sartori, S., Vogel, B., Leone, P. P., Smith, K., Bay, B., Krishnan, P., Sweeny, J., Oliva, A., Moreno, P., Gilhooley, S., Di Muro, F. M., Krishnamoorthy, P. M., Kini, A., Dangas, G., Mehran, R., & Sharma, S. (2025). Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention. Canadian Journal of Cardiology. https://doi.org/10.1016/j.cjca.2025.02.035

Vancouver

Gitto M, Sartori S, Vogel B, Leone PP, Smith K, Bay B, et al. Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention. Canadian Journal of Cardiology. 2025. doi:10.1016/j.cjca.2025.02.035

BibTeX
@article{Gitto2025,
  author = {Gitto, Mauro and Sartori, Samantha and Vogel, Birgit and Leone, Pier Pasquale and Smith, Kenneth and Bay, Benjamin and Krishnan, Prakash and Sweeny, Joseph and Oliva, Angelo and Moreno, Pedro and Gilhooley, Sean and Di Muro, Francesca Maria and Krishnamoorthy, Parasuram Melarcode and Kini, Annapoorna and Dangas, George and Mehran, Roxana and Sharma, Samin},
  title = {Potent P2Y12 Inhibitors vs Clopidogrel in Cancer Patients Undergoing Percutaneous Coronary Intervention},
  journal = {Canadian Journal of Cardiology},
  year = {2025},
  doi = {10.1016/j.cjca.2025.02.035}
}
Kostenlos starten →